Protective effect of N-acetylcysteine against carmustine-induced myelotoxicity in rats

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1576-1580

  El Sayed, El Sayed M ^a   Abdel Aziz, Abdel Aziz H ^a   Helal, Gouda K ^a   Saleh, Samira ^b   Saad, Ahmed S ^b  

^a Al Azhar University   (Egypt)

^b OCTOBER 6 UNIVERSITY   (Egypt)

Author keywords

Carmustine; Myelosuppression; NAC

Indexed keywords

ACETYLCYSTEINE; CARMUSTINE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; BONE MARROW TOXICITY; CELL LYSATE; CONTROLLED STUDY; HEMATOLOGICAL PARAMETERS; LEUKOCYTE COUNT; MALE; NONHUMAN; PROTECTION; RAT; THROMBOCYTE COUNT;

ACETYLCYSTEINE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW CELLS; CARMUSTINE; MALE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 77952883380     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.027     Document Type: Article

References (57)

1. Abushamaa A.M., Sporn T.A., Folz R.J. Oxidative stress and inflammation contribute to lung toxicity after a common breast cancer chemotherapy regimen. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:336-345.
2. Aebi H.E. Catalase. Methods of Enzymatic Analysis 1983, 273-282. Verlag Chemie, Weinheim. H.U. Bergmeyer (Ed.).
3. Ahmad T., Frischer H. Active site-specific inhibition by 1,3-bis(2-chloroethyl)-1-nitrosourea of two genetically homologous flavoenzymes: glutathione reductase and lipoamide dehydrogenase. J. Lab. Clin. Med. 1985, 105:464-471.
4. Alexandre J., Nicco C., Chéreau C., Laurent A., Weill B., Goldwasser F., Batteux F. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J. Natl. Cancer Inst. 2006, 98(4):236-245.
5. Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 1989, 6:593-597.
6. Attia S.M., Helal G.K., Alhaider A.A. Assessment of genomic instability in normal and diabetic rats treated with metformin. Chem. Biol. Interact. 2009, 180(2):296-304.
7. Bailey H.H., Mulcahy R.T., Tutsch K.D., Arzoomanian R.Z., Alberti D., Tombes M.B., Wilding G., Pomplun M., Spriggs D.R. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J. Clin. Oncol. 1994, 12:194-205.
8. Bailey H.H., Ripple G., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., Mahvi D., Schink J., Pomplun M., Mulcahy R.T., Wilding G. Phase I study of continuous-infusion L-S, R-buthionine sulfoximine with intravenous melphalan. J. Natl. Cancer Inst. 1997, 89:1789-1796.
9. Bernard G.R. N-acetylcysteine in experimental and clinical acute lung injury. Am. J. Med. 1991, 91:54S-59S.
10. Bolliger A.P. Cytologic evaluation of bone marrow in rats: indications, methods, and normal morphology. Vet. Clin. Pathol. 2004, 33(2):58-67.
11. Brundrett R.B. Chemistry of nitrosoureas. Intermediacy of 4,5-dihydro-1,2,3-oxadiazole in 1,3-bis(2-chloroethyl)-1-nitrosourea decomposition. J. Med. Chem. 1980, 23:1245-1270.
12. Cetinkaya A., Bulbuloglu E., Kurutas E.B., Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med. Sci. Monit. 2006, 12(8):BR274-BR278.
13. Chavez-Cartaya R., Jamieson N.V., Ramirez P., Marin J., Pino-Chavez G. Free radical scavengers to prevent reperfusion injury following experimental warm liver ischaemia. Is there a real physiological benefit?. Transpl. Int. 1999, 12:213-221.
14. Chu E., Sartorelli A.C. Cancer chemotherapy. Basic and Clinical Pharmacology 2007, 878-907. McGraw Hill Medical, Chapter 55. B.G. Katzung (Ed.).
15. Ewing J.E., Janero D.R. Microplate superoxide dismutase assay employing non-enzymatic superoxide generator. Anal. Biochem. 1995, 232:243-248.
16. Fanger G.R., Gerwins P., Widmann C., Jarpe M.B., Johnson G.L. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: upstream regulators of c-Jun aminoterminal kinases?. Curr. Opin. Genet. Dev. 1997, 7:67-74.
17. Frischer H., Kennedy E.J., Chigurupati R., Sivarajan M. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia. J. Clin. Invest. 1993, 92:2761-2767.
18. Fukuzawa K., Emre S., Senyuz O., Acarli K., Schwartz M., Miller C. N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 1995, 59:6-9.
19. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 1986, 7:745-749.
20. Griffith O.W. Determination of glutathione and glutathione disulphide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 1981, 106:207-212.
21. Hagen T.M., Aw T.Y., Jones D.P. Glutathione uptake and protection against oxidative injury in isolated kidney cells. Kidney Int. 1988, 34(1):74-81.
22. 2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 2002, 9:163-173.
23. Helal G.K., Helal O.K. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats. Arch. Toxicol. 2009, 83(1):87-94.
24. Herson P.S., Lee K., Pinnock R.D., Hughes J., Ashford M.L.J. Hydrogen peroxide induces intracellular calcium overload by activation of a nonselective cation channel in an insulin-secreting cell line. J. Biol. Chem. 1999, 274:833-841.
25. Ip Y.T., Davis R.J. Signal transduction by the c-Jun-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell Biol. 1998, 10:205-219.
26. Jayalakshmi K., Singh S.B., Kalpana B., Sairam M., Muthuraju S., Ilavazhagan G. N-acetyl cysteine supplementation prevents impairment of spatial working memory functions in rats following exposure to hypobaric hypoxia. Physiol. Behav. 2007, 92:643-650.
27. Kohn K.W. Interstrand cross-linking of DNA by 1,3-Bis (2-cholorethyl)-l-nitrosourea and other 1-(2-cholorethyl)-l-nitrosourea. Cancer Res. 1977, 37:1450-1454.
28. Koliwad S.K., Elliott S.J., Kunze D.L. Oxidized glutathione mediates cation channel activation in calf vascular endothelial cells during oxidant stress. J. Physiol. 1996, 495:37-49.
29. Larrick J.W., Wright S.C. Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 1990, 4(14):3215-3223.
30. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 1976, 71:952-958.
31. Lytle R.A., Jiang Z., Zheng X., Rich K.M. BCNU down-regulates anti-apoptotic proteins Bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells. J. Neurooncol. 2004, 68:233-241.
32. Malorni W., Rivabene R., Santini M.T., Rainaldi G., Donelli G. N-acetylcysteine prevents TNF-induced mitochondrial damage, apoptosis and viral particle production in HIV-infected U937 cells. Redox Rep. 1994, 1:57-64.
33. Maxwell S.R. Prospects for the use of antioxidant therapies. Drugs 1995, 49(3):345-361.
34. May J.M., Qu Z.C., Nelson D.J. Cellular disulfide-reducing capacity: an integrated measure of cell redox capacity. Biochem. Biophys. Res. Commun. 2006, 344:1352-1359.
35. Maze R., Carney J.P., Kelley M.R., Glassner B.J., Williams D.A., Samson L. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl. Acad. Sci. 1996, 93:206-210.
36. Mihara M., Uchiyama M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86(1):271-278.
37. Moritz T., Mackay W., Glassner B.J., Williams D.A., Samson L. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res. 1995, 55:2608-2614.
38. 2+ levels through the activation of nonselective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J. Biol. Chem. 2002, 277:24717-24727.
39. Ortolani O., Conti A., De Gaudio A.R., Moraldi E., Cantini Q., Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am. J. Respir. Crit. Care Med. 2000, 161(6):1907-1911.
40. Paget G.E., Barnes J.M. Interspecies dosage conversion scheme in evaluation of results and quantitative application in different species. Evaluation of Drug Activities: Pharmacometrics 1964, vol. I:160-162. Academic Press, London, New York.
41. Parchment R.E., Gordon M., Grieshaber C.K., Sessa C., Volpe D., Ghielmini M. Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests. Ann. Oncol. 1998, 9:357-364.
42. Pessina A., Albella B., Bayo M., Bueren J., Brantom P., Casati S., Croera C., Gagliardi G., Foti P., Parchment R., Parent-Massin D., Schoeters G., Sibiril Y., Van Den Heuvel R., Gribaldo L. Application of the CFU-GM Assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol. Sci. 2003, 75:355-367.
43. Riley V. Adaptation of orbital bleeding technic to rapid serial blood studies. Proc. Soc. Exp. Biol. Med. 1960, 104:751-754.
44. Sagara M., Satoh J., Wada R., Yagihashi S., Takahashi K., Fukuzawa M., Muto G., Muto Y., Toyota T. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 1996, 39:38-43.
45. Sarnstrand A., Tunek A., Sjodin N. Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats. Chem. Biol. Interact. 1995, 94:157-164.
46. Sato M., Miyazaki T., Nagaya T., Murata Y., Ida N., Maeda K., Seo H. Antioxidants inhibit TNF-α mediated stimulation of IL-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J. Rheumatol. 1996, 23:28-34.
47. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
48. Sorg D.A., Buckner B. A simple method of obtaining venous blood from small laboratory animals. Proc. Soc. Exp. Biol. Med. 1964, 115:1131-1132.
49. Sundaresan S., Subramanian P. S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis. Pol. J. Pharmacol. 2003, 55(1):37-42.
50. 0-bis(2-chloroethyl)-N-nitrosourea. Cancer Res. 1982, 42(8):3102-3105.
51. Vivot C., Stump M., Schartz M., Theise N., Miller C. N-acetylcysteine attenuates cold ischemia/reperfusion injury in the isolated perfused rat liver. Transplant. Proc. 1993, 25:1983-1984.
52. Vo T.K., Druez C., Delzenne N., Taper H.S., Roberfroid M. Analysis of antioxidant defense systems during rat hepatocarcinogenesis. Carcinogenesis 1988, 9(11):2009-2013.
53. Volpe D.A., Warren M.K. Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents. Toxicol. In Vitro 2003, 17:271-277.
54. Weydert C.J.D., Smith B.B., Xu L., Kregel K.C., Ritchie J.M., Davis C.S., Oberley L.W. Inhibition of oral cancer cell growth by adenovirus MnSOD plus BCNU treatment. Free Radic. Biol. Med. 2003, 34(3):316-329.
55. Wu Y.J., Muldoon L.L., Neuwelt E.A. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J. Pharmacol. Exp. Ther. 2005, 312:424-431.
56. Zafarullah M., Lia W.Q., Sylvester J., Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 2003, 60:6-20.
57. Zhang H., Spapen H., Nguyen D.H., Rogiers P., Bakker J., Vincent J.L. Effects of NAC on regional blood flow during endotoxic shock. Eur. Surg. Res. 1995, 27:292-300.